Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients

PURPOSE: The aim of this study was to investigate potential markers of coagulopathy and the effects of thromboprophylaxis with low-molecular-weight heparin (LMWH) on thromboelastography (TEG) and anti-factor Xa in critically ill COVID-19 patients. MATERIAL AND METHODS: We conducted a prospective stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Crit Care
Autors principals: Stattin, K., Lipcsey, M., Andersson, H., Pontén, E., Bülow Anderberg, S., Gradin, A., Larsson, A., Lubenow, N., von Seth, M., Rubertsson, S., Hultström, M., Frithiof, R.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Inc. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470731/
https://ncbi.nlm.nih.gov/pubmed/32920503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcrc.2020.08.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars